Pharming Group to participate in March investor conference

Rhea-AI Summary

Pharming Group (Euronext: PHARM/Nasdaq: PHAR) has announced its participation in the upcoming 37th Annual Roth Conference in Dana Point, California, scheduled for March 16-18, 2025.

The company's Chief Medical Officer Anurag Relan and VP Investor Relations and Corporate Communications Michael Levitan will engage in a fireside chat and Q&A session on March 17, 2025, at 1:30 PM PT/21:30 CET.

Investors interested in one-on-one meetings with Pharming's management team can arrange appointments through the company's Investor Relations team or their Roth representative.

Leiden, the Netherlands, February 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of March:

• 37^th Annual Roth Conference, Dana Point, CA, USA, March 16-18, 2025
  Anurag Relan, Chief Medical Officer, and Michael Levitan, VP Investor Relations and Corporate Communications, will participate in a fireside chat question and answer session on Monday, March 17 at 01:30pm PT/21:30 CET.

For more information about this conference, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Roth representative.

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com

FTI Consulting, London, United Kingdom
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

Attachment

• Pharming attending Investor Conferences March 2025_EN_28FEB25

FAQ

When is Pharming Group (PHARM) presenting at the 37th Annual Roth Conference 2025?

Pharming Group will present on Monday, March 17, 2025, at 1:30 PM PT/21:30 CET.

Which Pharming Group executives will attend the Roth Conference 2025?

Chief Medical Officer Anurag Relan and VP Investor Relations Michael Levitan will participate in a fireside chat.

How can investors schedule meetings with Pharming Group (PHARM) management at the Roth Conference?

Investors can schedule meetings by contacting Pharming's IR team at investor@pharming.com or through their Roth representative.

Where will the 37th Annual Roth Conference featuring Pharming Group (PHARM) take place?

The conference will be held in Dana Point, California, USA.

What type of presentation will Pharming Group (PHARM) deliver at the Roth Conference?

Pharming Group will participate in a fireside chat question and answer session.